Melody Swartz
8Patents
3h-index
23Co-inventors
53Inventor score
Filing activity: Feb 19, 2007 → Mar 5, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8323696B2 | Nanoparticles for immunotherapy | Human Necessities | 32 | Active |
| US8021689B2 | Nanoparticles for immunotherapy | Human Necessities | 29 | Active |
| US8592364B2 | CCR7 ligand delivery and co-delivery in immunotherapy | Chemistry; Metallurgy | 26 | Active |
| US9271929B2 | Block copolymers and uses thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US10335499B2 | Block copolymers and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11574747B2 | Methods of treating cancer with placenta growth factor peptide linked to immunotherapeutic antibodies | Physics | 0 | Active |
| US10980877B2 | Method for treating melanoma using lymphangiogenesis inducers and a melanoma-specific antigen | Physics | 0 | Active |
| US12365714B2 | Methods and compositions for treating cancer with ECM-affinity peptides linked to cytokines | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.